Report Detail
Global Personalized Medicine and Epigenomics Market Size, Status and Forecast 2019-2025
- RnM2989250 |
- 20 February, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Other
Epigenomics is the study of the complete set of epigenetic modifications on the genetic material of a cell, known as the epigenome. The field is analogous to genomics and proteomics, which are the study of the genome and proteome of a cell.
In 2018, the global Personalized Medicine and Epigenomics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Personalized Medicine and Epigenomics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Personalized Medicine and Epigenomics development in United States, Europe and China.
The key players covered in this study
Abbott Laboratories
Affymetrix
Agilent Technologies
Astellas Pharmaceuticals
BAYER AG
Bio Vision
Celgene Corp.
Emd Millipore
Epigenomics AG
Epigentex
Envivo Pharmaceuticals (Forum Pharmaceutricals)
Gilead Sciences
Glaxosmithkline
Illumina Inc.
Johnson & Johnson
Karus Therapeutics Limited
Laboratory Corp. Of America Holdings
LES Laboratoires Servier
Merck
Naturewise Biotech & Medicals Corp.
Novartis Pharma AG
Oncolys Biopharma Inc.
Orchid Chemicals & Pharmaceuticals Limited
Progen Pharmaceuticals Limited
Quest Diagnostics
Roche Holding AG
Rubicon Genomics
Takeda Pharmaceutical Company Limited
Market segment by Type, the product can be split into
Reagents
Kits
Instruments
Enzymes
Services
Market segment by Application, split into
Oncology
Non-Oncology
Cancer Drug Technology
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Personalized Medicine and Epigenomics status, future forecast, growth opportunity, key market and key players.
To present the Personalized Medicine and Epigenomics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Personalized Medicine and Epigenomics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Personalized Medicine and Epigenomics Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Reagents
- 1.4.3 Kits
- 1.4.4 Instruments
- 1.4.5 Enzymes
- 1.4.6 Services
- 1.5 Market by Application
- 1.5.1 Global Personalized Medicine and Epigenomics Market Share by Application (2014-2025)
- 1.5.2 Oncology
- 1.5.3 Non-Oncology
- 1.5.4 Cancer Drug Technology
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Personalized Medicine and Epigenomics Market Size
- 2.2 Personalized Medicine and Epigenomics Growth Trends by Regions
- 2.2.1 Personalized Medicine and Epigenomics Market Size by Regions (2014-2025)
- 2.2.2 Personalized Medicine and Epigenomics Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Personalized Medicine and Epigenomics Market Size by Manufacturers
- 3.1.1 Global Personalized Medicine and Epigenomics Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Personalized Medicine and Epigenomics Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Personalized Medicine and Epigenomics Market Concentration Ratio (CR5 and HHI)
- 3.2 Personalized Medicine and Epigenomics Key Players Head office and Area Served
- 3.3 Key Players Personalized Medicine and Epigenomics Product/Solution/Service
- 3.4 Date of Enter into Personalized Medicine and Epigenomics Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Personalized Medicine and Epigenomics Market Size by Type (2014-2019)
- 4.2 Global Personalized Medicine and Epigenomics Market Size by Application (2014-2019)
5 United States
- 5.1 United States Personalized Medicine and Epigenomics Market Size (2014-2019)
- 5.2 Personalized Medicine and Epigenomics Key Players in United States
- 5.3 United States Personalized Medicine and Epigenomics Market Size by Type
- 5.4 United States Personalized Medicine and Epigenomics Market Size by Application
6 Europe
- 6.1 Europe Personalized Medicine and Epigenomics Market Size (2014-2019)
- 6.2 Personalized Medicine and Epigenomics Key Players in Europe
- 6.3 Europe Personalized Medicine and Epigenomics Market Size by Type
- 6.4 Europe Personalized Medicine and Epigenomics Market Size by Application
7 China
- 7.1 China Personalized Medicine and Epigenomics Market Size (2014-2019)
- 7.2 Personalized Medicine and Epigenomics Key Players in China
- 7.3 China Personalized Medicine and Epigenomics Market Size by Type
- 7.4 China Personalized Medicine and Epigenomics Market Size by Application
8 Japan
- 8.1 Japan Personalized Medicine and Epigenomics Market Size (2014-2019)
- 8.2 Personalized Medicine and Epigenomics Key Players in Japan
- 8.3 Japan Personalized Medicine and Epigenomics Market Size by Type
- 8.4 Japan Personalized Medicine and Epigenomics Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Personalized Medicine and Epigenomics Market Size (2014-2019)
- 9.2 Personalized Medicine and Epigenomics Key Players in Southeast Asia
- 9.3 Southeast Asia Personalized Medicine and Epigenomics Market Size by Type
- 9.4 Southeast Asia Personalized Medicine and Epigenomics Market Size by Application
10 India
- 10.1 India Personalized Medicine and Epigenomics Market Size (2014-2019)
- 10.2 Personalized Medicine and Epigenomics Key Players in India
- 10.3 India Personalized Medicine and Epigenomics Market Size by Type
- 10.4 India Personalized Medicine and Epigenomics Market Size by Application
11 Central & South America
- 11.1 Central & South America Personalized Medicine and Epigenomics Market Size (2014-2019)
- 11.2 Personalized Medicine and Epigenomics Key Players in Central & South America
- 11.3 Central & South America Personalized Medicine and Epigenomics Market Size by Type
- 11.4 Central & South America Personalized Medicine and Epigenomics Market Size by Application
12 International Players Profiles
- 12.1 Abbott Laboratories
- 12.1.1 Abbott Laboratories Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Personalized Medicine and Epigenomics Introduction
- 12.1.4 Abbott Laboratories Revenue in Personalized Medicine and Epigenomics Business (2014-2019)
- 12.1.5 Abbott Laboratories Recent Development
- 12.2 Affymetrix
- 12.2.1 Affymetrix Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Personalized Medicine and Epigenomics Introduction
- 12.2.4 Affymetrix Revenue in Personalized Medicine and Epigenomics Business (2014-2019)
- 12.2.5 Affymetrix Recent Development
- 12.3 Agilent Technologies
- 12.3.1 Agilent Technologies Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Personalized Medicine and Epigenomics Introduction
- 12.3.4 Agilent Technologies Revenue in Personalized Medicine and Epigenomics Business (2014-2019)
- 12.3.5 Agilent Technologies Recent Development
- 12.4 Astellas Pharmaceuticals
- 12.4.1 Astellas Pharmaceuticals Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Personalized Medicine and Epigenomics Introduction
- 12.4.4 Astellas Pharmaceuticals Revenue in Personalized Medicine and Epigenomics Business (2014-2019)
- 12.4.5 Astellas Pharmaceuticals Recent Development
- 12.5 BAYER AG
- 12.5.1 BAYER AG Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Personalized Medicine and Epigenomics Introduction
- 12.5.4 BAYER AG Revenue in Personalized Medicine and Epigenomics Business (2014-2019)
- 12.5.5 BAYER AG Recent Development
- 12.6 Bio Vision
- 12.6.1 Bio Vision Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Personalized Medicine and Epigenomics Introduction
- 12.6.4 Bio Vision Revenue in Personalized Medicine and Epigenomics Business (2014-2019)
- 12.6.5 Bio Vision Recent Development
- 12.7 Celgene Corp.
- 12.7.1 Celgene Corp. Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Personalized Medicine and Epigenomics Introduction
- 12.7.4 Celgene Corp. Revenue in Personalized Medicine and Epigenomics Business (2014-2019)
- 12.7.5 Celgene Corp. Recent Development
- 12.8 Emd Millipore
- 12.8.1 Emd Millipore Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Personalized Medicine and Epigenomics Introduction
- 12.8.4 Emd Millipore Revenue in Personalized Medicine and Epigenomics Business (2014-2019)
- 12.8.5 Emd Millipore Recent Development
- 12.9 Epigenomics AG
- 12.9.1 Epigenomics AG Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Personalized Medicine and Epigenomics Introduction
- 12.9.4 Epigenomics AG Revenue in Personalized Medicine and Epigenomics Business (2014-2019)
- 12.9.5 Epigenomics AG Recent Development
- 12.10 Epigentex
- 12.10.1 Epigentex Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Personalized Medicine and Epigenomics Introduction
- 12.10.4 Epigentex Revenue in Personalized Medicine and Epigenomics Business (2014-2019)
- 12.10.5 Epigentex Recent Development
- 12.11 Envivo Pharmaceuticals (Forum Pharmaceutricals)
- 12.12 Gilead Sciences
- 12.13 Glaxosmithkline
- 12.14 Illumina Inc.
- 12.15 Johnson & Johnson
- 12.16 Karus Therapeutics Limited
- 12.17 Laboratory Corp. Of America Holdings
- 12.18 LES Laboratoires Servier
- 12.19 Merck
- 12.20 Naturewise Biotech & Medicals Corp.
- 12.21 Novartis Pharma AG
- 12.22 Oncolys Biopharma Inc.
- 12.23 Orchid Chemicals & Pharmaceuticals Limited
- 12.24 Progen Pharmaceuticals Limited
- 12.25 Quest Diagnostics
- 12.26 Roche Holding AG
- 12.27 Rubicon Genomics
- 12.28 Takeda Pharmaceutical Company Limited
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Personalized Medicine and Epigenomics . Industry analysis & Market Report on Personalized Medicine and Epigenomics is a syndicated market report, published as Global Personalized Medicine and Epigenomics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Personalized Medicine and Epigenomics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
